![](/img/cover-not-exists.png)
PCN108 SOCIETAL COST SAVINGS ASSOCIATED WITH BEVACIZUMAB-BASED TREATMENT IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN ITALY
E Mueller, M Nuijten, S Ravera, S Stanisic, S WalzerVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)72003-4
File:
PDF, 97 KB
english, 2010